BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 31435431)

  • 1. The Effect of High Dose Rate Interstitial Implant on Early and Locally Advanced Oral Cavity Cancers: Update and Long-Term Follow-Up Study.
    Vedasoundaram P; Raghava Ks A; Periasamy K; Selvarajan G; K S; Kandasamy S; R S; Kumar A
    Cureus; 2020 May; 12(5):e7910. PubMed ID: 32494525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Tissue Classification Using a Novel Optical Needle Probe for Biopsy.
    Surazynski L; Hassinen V; Nieminen MT; Seppänen T; Myllylä T
    Appl Spectrosc; 2024 May; 78(5):477-485. PubMed ID: 38373402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of boost dose for T4 nasopharyngeal carcinoma with residual primary lesion after intensity-modulated radiotherapy.
    Fei Z; Xu T; Qiu X; Li M; Chen T; Li L; Huang C; Chen C
    J Cancer Res Clin Oncol; 2021 Jul; 147(7):2047-2055. PubMed ID: 33392660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
    Mendez LC; Weiss Y; D'Souza D; Ravi A; Barbera L; Leung E
    Radiother Oncol; 2017 May; 123(2):312-318. PubMed ID: 28351521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma?
    Teo PM; Kwan WH; Chan AT; Lee WY; King WW; Mok CO
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):897-913. PubMed ID: 9531376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibre-optic endoscope-guided three-dimensional high-dose-rate interstitial brachytherapy for residual nasopharyngeal carcinoma after conventional external beam radiotherapy.
    Zhang X; Wu N; Zhao Z; Han D; He M; Yang W; Cheng G
    J Contemp Brachytherapy; 2019 Jun; 11(3):243-249. PubMed ID: 31435431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Dose-Rate Interstitial Brachytherapy for Deeply Situated Gynecologic Tumors Guided by Combination of Transrectal and Transabdominal Ultrasonography: A Technical Note.
    Shimizu Y; Murakami N; Chiba T; Kaneda T; Okamoto H; Nakamura S; Takahashi A; Kashihara T; Takahashi K; Inaba K; Okuma K; Nakayama Y; Itami J; Igaki H
    Front Oncol; 2021; 11():808721. PubMed ID: 35155202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-guided interstitial brachytherapy boost for keratinizing squamous cell carcinoma of inferior wall of the nasopharynx.
    Murakami N; Yoshimoto S; Uematsu M; Kashihara T; Takahashi K; Inaba K; Okuma K; Igaki H; Nakayama Y; Masui K; Yoshida K; Itami J
    BJR Case Rep; 2020 Dec; 6(4):20200005. PubMed ID: 33299579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful salvage treatment of refractory recurrence of maxillary sinus carcinoma using image-guided high-dose-rate interstitial brachytherapy.
    Zhang Y; Wu N; Zhao Z; Chen Q; Cheng G
    J Contemp Brachytherapy; 2018 Apr; 10(2):162-168. PubMed ID: 29789765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-guided interstitial brachytherapy boost for nasopharyngeal carcinoma: technical aspects.
    Murakami N; Cheng G; Yoshimoto S; Itami J
    J Contemp Brachytherapy; 2020 Jun; 12(3):294-302. PubMed ID: 32695204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscope-guided interstitial intensity-modulated brachytherapy and intracavitary brachytherapy as boost radiation for primary early T stage nasopharyngeal carcinoma.
    Wan XB; Jiang R; Xie FY; Qi ZY; Li AJ; Ye WJ; Hua YJ; Zhu YL; Zou X; Guo L; Mai HQ; Guo X; Hong MH; Chen MY
    PLoS One; 2014; 9(3):e90048. PubMed ID: 24595299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma.
    Ren YF; Gao YH; Cao XP; Ye WJ; Teh BS
    Radiat Oncol; 2010 Nov; 5():113. PubMed ID: 21092297
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.